VestGen Advisors’s Avanos Medical AVNS Stock Holding History

VestGen Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-101,063	Closed	-$2.5M	–	1093
2026 Q1	$2.5M	Buy	+101,063	New	+$1.36M	0.07%	263

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

VestGen Advisors's AVNS Position: Q2 2026 in Review

VestGen Advisors sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 101,063 shares — an estimated $2.5M sold.

VestGen Advisors first reported a position in AVNS in Q1 2026 and held it in 1 quarter. The position peaked at $2.5M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

VestGen Advisors reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
VestGen Advisors sold 101,063 Avanos Medical shares in Q2 2026, an estimated $2.5M.
VestGen Advisors first reported a position in Avanos Medical in Q1 2026 and held it in 1 quarter.
VestGen Advisors's Avanos Medical position peaked at $2.5M in Q1 2026.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.